FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012064275> ?p ?o ?g. }

• W2012064275 endingPage "68" @default.
• W2012064275 startingPage "61" @default.
• W2012064275 abstract "The importance of aggrecanase versus matrix metalloproteinase (MMP) enzymic activities in the degradation of aggrecan in normal and osteoarthritic (OA) articular cartilage in vitro was studied in order to further our understanding of the potential role of these two enzyme activities in aggrecan catabolism during the pathogenesis of cartilage degeneration. Porcine and bovine articular cartilage was maintained in explant culture for up to 20 days in the presence or absence of the catabolic stimuli retinoic acid, interleukin-1 or tumour necrosis factor-α. Release of proteoglycan from cartilage was measured as glycosaminoglycan (GAG) release using a colorimetric assay. Analysis of proteoglycan degradation products, both released into culture media and retained within the cartilage matrix, was performed by Western blotting using antibodies specific for the N- and C-terminal neoepitopes generated by aggrecanase- and MMP-related catabolism of the interglobular domain of the aggrecan core protein (IGD). In addition, studies determining the mRNA expression for MMP-3 and MMP-13 in these same cultures were undertaken. These analyses indicated that all three catabolic agents stimulated the release of &gt; 80% of the GAG from the articular cartilage over 4 days. The degree of GAG release corresponded to an increase in aggrecanase-generated aggrecan catabolites released into the media and retained within the cartilage. Importantly, there was no evidence for the release of MMP-generated aggrecan metabolites into the medium, nor the accumulation of MMP-generated catabolites within the tissue in these same cultures. Expression of the mRNAs for two MMPs known to be capable of degrading the aggrecan IGD, MMP-3 and MMP-13, was detected. However, increased expression of these MMPs was not correlated with aggrecan degradation. Analyses using porcine cartilage, cultured with or without catabolic stimulation for 12 h to 20 days, indicated that primary cleavage of the IGD by aggrecanase was responsible for release of aggrecan metabolites at both the early and late time points of culture. Cultures of late-stage OA human articular cartilage samples indicated that aggrecanase activity was upregulated in the absence of catabolic stimulation when compared with normal porcine or bovine cartilage. In addition, even in this late-stage degenerate cartilage, aggrecanase and not MMP activity was responsible for the release of the majority of aggrecan from the cartilage. This study demonstrates that the release of aggrecan from both normal and OA cartilage in response to catabolic stimulation in vitro involves a primary cleavage by aggrecanase and not MMPs." @default.
• W2012064275 created "2016-06-24" @default.
• W2012064275 creator A5002527454 @default.
• W2012064275 creator A5006447462 @default.
• W2012064275 creator A5012474280 @default.
• W2012064275 creator A5015269955 @default.
• W2012064275 creator A5026356126 @default.
• W2012064275 creator A5029535559 @default.
• W2012064275 creator A5085462956 @default.
• W2012064275 date "1999-11-08" @default.
• W2012064275 modified "2023-10-14" @default.
• W2012064275 title "Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan <i>in vitro</i>" @default.
• W2012064275 cites W109076851 @default.
• W2012064275 cites W1486701492 @default.
• W2012064275 cites W1490074841 @default.
• W2012064275 cites W1494656326 @default.
• W2012064275 cites W1525740558 @default.
• W2012064275 cites W1581640555 @default.
• W2012064275 cites W1588094592 @default.
• W2012064275 cites W1615883506 @default.
• W2012064275 cites W1712774648 @default.
• W2012064275 cites W1808369276 @default.
• W2012064275 cites W1973897421 @default.
• W2012064275 cites W1980056373 @default.
• W2012064275 cites W1992130282 @default.
• W2012064275 cites W1992837858 @default.
• W2012064275 cites W2017045877 @default.
• W2012064275 cites W2032255522 @default.
• W2012064275 cites W2034919108 @default.
• W2012064275 cites W2037270622 @default.
• W2012064275 cites W2040990919 @default.
• W2012064275 cites W2043147398 @default.
• W2012064275 cites W2056977500 @default.
• W2012064275 cites W2069448431 @default.
• W2012064275 cites W2071948888 @default.
• W2012064275 cites W2074860567 @default.
• W2012064275 cites W2076942388 @default.
• W2012064275 cites W2081969734 @default.
• W2012064275 cites W2082863082 @default.
• W2012064275 cites W2084995088 @default.
• W2012064275 cites W2086013842 @default.
• W2012064275 cites W2090695665 @default.
• W2012064275 cites W2106862840 @default.
• W2012064275 cites W2114769400 @default.
• W2012064275 cites W2144347714 @default.
• W2012064275 cites W2150828068 @default.
• W2012064275 cites W2155873300 @default.
• W2012064275 cites W2236998588 @default.
• W2012064275 cites W2335897943 @default.
• W2012064275 cites W2338545152 @default.
• W2012064275 cites W2414375689 @default.
• W2012064275 cites W2417015271 @default.
• W2012064275 doi "https://doi.org/10.1042/bj3440061" @default.
• W2012064275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1220614" @default.
• W2012064275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10548534" @default.
• W2012064275 hasPublicationYear "1999" @default.
• W2012064275 type Work @default.
• W2012064275 sameAs 2012064275 @default.
• W2012064275 citedByCount "119" @default.
• W2012064275 countsByYear W20120642752012 @default.
• W2012064275 countsByYear W20120642752013 @default.
• W2012064275 countsByYear W20120642752014 @default.
• W2012064275 countsByYear W20120642752015 @default.
• W2012064275 countsByYear W20120642752016 @default.
• W2012064275 countsByYear W20120642752017 @default.
• W2012064275 countsByYear W20120642752018 @default.
• W2012064275 countsByYear W20120642752019 @default.
• W2012064275 countsByYear W20120642752020 @default.
• W2012064275 countsByYear W20120642752021 @default.
• W2012064275 countsByYear W20120642752022 @default.
• W2012064275 countsByYear W20120642752023 @default.
• W2012064275 crossrefType "journal-article" @default.
• W2012064275 hasAuthorship W2012064275A5002527454 @default.
• W2012064275 hasAuthorship W2012064275A5006447462 @default.
• W2012064275 hasAuthorship W2012064275A5012474280 @default.
• W2012064275 hasAuthorship W2012064275A5015269955 @default.
• W2012064275 hasAuthorship W2012064275A5026356126 @default.
• W2012064275 hasAuthorship W2012064275A5029535559 @default.
• W2012064275 hasAuthorship W2012064275A5085462956 @default.
• W2012064275 hasBestOaLocation W20120642752 @default.
• W2012064275 hasConcept C105702510 @default.
• W2012064275 hasConcept C109523444 @default.
• W2012064275 hasConcept C142724271 @default.
• W2012064275 hasConcept C153074725 @default.
• W2012064275 hasConcept C153911025 @default.
• W2012064275 hasConcept C181199279 @default.
• W2012064275 hasConcept C185592680 @default.
• W2012064275 hasConcept C189165786 @default.
• W2012064275 hasConcept C197534660 @default.
• W2012064275 hasConcept C204787440 @default.
• W2012064275 hasConcept C2776157581 @default.
• W2012064275 hasConcept C2776164576 @default.
• W2012064275 hasConcept C2779335624 @default.
• W2012064275 hasConcept C2780550940 @default.
• W2012064275 hasConcept C3020332539 @default.
• W2012064275 hasConcept C55493867 @default.
• W2012064275 hasConcept C55728118 @default.
• W2012064275 hasConcept C71924100 @default.

• next